Get started
Author

Kiran Kumar Rathinam

Observed names: Kiran Kumar Rathinam, Kiran Kumar R
ORCID: 0000-0002-0912-3969
Observed ORCID: 0000-0002-0912-3969
OpenAlex ID: A5064785903
Safety and Efficacy of Saroglitazar in Nonalcoholic Fatty Liver Patients With Diabetic Dyslipidemia—A Prospective, Interventional, Pilot Study
2021 · N.A. Rajesh, L. Drishya, et al. · Journal of Clinical and Experimental Hepatology · 30
PDF
Dupilumab in the Treatment of Moderate to Severe Asthma: An Evidence-Based Review
2019 · Kiran Kumar Rathinam, Justin Jacob Abraham, et al. · Current Therapeutic Research · 24
PDF
Pharmacist led intervention towards management of type 2 diabetes mellitus and assessment of patient satisfaction of care - A prospective, randomized controlled study
2021 · Manithottiyle Angelo Simon, Bandaru Yeswanth Raja, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 19
Evaluation of pharmacological interventions in the management of adenomyosis: a systematic review
2022 · Kiran Kumar Rathinam, Justin Jacob Abraham, et al. · European Journal of Clinical Pharmacology · 17
Role of fluoxetine in pharmacological enhancement of motor functions in stroke patients: A randomized, placebo-controlled, single-blind trial
2021 · Karthickeyan Krishnan, Muthuraj K, et al. · Contemporary Clinical Trials Communications · 5
Phenytoin induced Stevens-Johnson Syndrome-toxic Epidermal Necrolysis Overlap Exacerbated by Cephalexin in a 65-Year-old Neurosurgical Patient: A Rare Case Report
2021 · Vijayakumar Thangavel Mahalingam, Kiran Kumar Rathinam, et al. · Current Drug Research Reviews · 5
Prevalence of Methicillin-Resistant Staphylococcus Aureus (MRSA) in India: A Systematic Review and Meta-Analysis
2022 · Jagadeesan M, Kiran Kumar Rathinam, et al. · SSRN Electronic Journal · 3
Evaluation of Endpoints Used in Clinical Trials on Adenomyosis - A Systematic Review
2023 · Melvin George, Kiran Kumar Rathinam, et al. · Reviews on Recent Clinical Trials · 2
Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19
2021 · I Jerlin Michelle, S. A. Shevaani, et al. · Current Medicine Research and Practice · 1
Progression of Type-2 Diabetes Mellitus Associated with Pulmonary Tuberculosis Sequelae in a 60 Year Old Hypertensive Patient: A Multifactorial Case Report with Literature Review
2020 · Nuthalapati Poojith, Kiran Kumar Rathinam, et al. · Acta Scientific Pharmaceutical Sciences · 1
PDF
Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19
2021 · Justin Jacob Abraham, I Jerlin Michelle, et al. · Current Medicine Research and Practice
A Case Study on Schizophrenia Induced Multiple Comorbidities
2018 · Jagadeesan M, Kiran Kumar R, et al. · Asian Journal of Pharmaceutical and Clinical Research
PDF
Evaluation of self medication among professional students of Rajampet
2012 · Lokanath N, Ramkanth S, et al. · DOAJ (DOAJ: Directory of Open Access Journals)
Works count: 13
Citation count: 107
H-index: 5
I10-index: 4
Year
Topic
Type